Can pharmacological manipulation of LTP favor the effects of motor rehabilitation in multiple sclerosis?

Background: Synaptic plasticity, the basic mechanism of clinical recovery after brain lesion, can also remarkably influence the clinical course of multiple sclerosis (MS). Physical rehabilitation represents the main treatment option to promote synaptic long-term potentiation (LTP) and to enhance spontaneous recovery of neurological deficits. Objectives: To overview the role of pharmacological treatment and physical rehabilitation in modulating LTP and enhancing clinical recovery in MS. Results: Drug-induced LTP enhancement can be effectively used to promote functional recovery, alone or combined with rehabilitation. Also, as inflammatory cytokines alter synaptic transmission and plasticity in MS, pharmacological resolution of inflammation can positively influence clinical recovery. Finally, physical exercise could be an independent factor able to preserve or enhance LTP reserve both influencing signaling pathways involved in plasticity induction and maintenance, and decreasing inflammation. Future directions: Better knowledge of LTP determinants may be useful to design specific strategies to promote recovery after a relapse and to reduce the progressive neurological deterioration in MS patients.

[1]  P. Calabresi,et al.  Persistent activation of microglia and NADPH drive hippocampal dysfunction in experimental multiple sclerosis , 2016, Scientific Reports.

[2]  D. Centonze,et al.  CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis , 2014, Neurology: Neuroimmunology & Neuroinflamm.

[3]  D. Centonze,et al.  Free D-aspartate regulates neuronal dendritic morphology, synaptic plasticity, gray matter volume and brain activity in mammals , 2014, Translational Psychiatry.

[4]  D. Centonze,et al.  Cortical plasticity predicts recovery from relapse in multiple sclerosis , 2014, Multiple sclerosis.

[5]  D. Centonze,et al.  Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis , 2014, Journal of Neuroinflammation.

[6]  W. van Hecke,et al.  Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial , 2014, Trials.

[7]  D. Centonze,et al.  Synaptic Plasticity and PDGF Signaling Defects Underlie Clinical Progression in Multiple Sclerosis , 2013, The Journal of Neuroscience.

[8]  M. Juliano,et al.  Differential brain and spinal cord cytokine and BDNF levels in experimental autoimmune encephalomyelitis are modulated by prior and regular exercise , 2013, Journal of Neuroimmunology.

[9]  N. Paik,et al.  Effect of the Presence of Brain-Derived Neurotrophic Factor Val66Met Polymorphism on the Recovery in Patients With Acute Subcortical Stroke , 2013, Annals of rehabilitation medicine.

[10]  F. Gamelin,et al.  The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity , 2012, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[11]  G. Pizzolato,et al.  Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis , 2012, Journal of the Neurological Sciences.

[12]  D. Centonze,et al.  Early treatment with high-dose interferon beta-1a reverses cognitive and cortical plasticity deficits in multiple sclerosis. , 2012, Functional neurology.

[13]  E. Castrén,et al.  Fear Erasure in Mice Requires Synergy Between Antidepressant Drugs and Extinction Training , 2011, Science.

[14]  P. Pasqualetti,et al.  P25.4 Motor cortex plasticity predicts recovery in acute stroke , 2010, Clinical Neurophysiology.

[15]  Alessandro Martorana,et al.  Exercise attenuates the clinical, synaptic and dendritic abnormalities of experimental autoimmune encephalomyelitis , 2009, Neurobiology of Disease.

[16]  D. Centonze,et al.  Cannabis-based treatment induces polarity-reversing plasticity assessed by theta burst stimulation in humans , 2009, Brain Stimulation.

[17]  J. Sepulcre,et al.  Memantine induces reversible neurologic impairment in patients with MS , 2009, Neurology.

[18]  P. Castillo,et al.  Endocannabinoid signaling and long-term synaptic plasticity. , 2009, Annual review of physiology.

[19]  Giacomo Koch,et al.  A common polymorphism in the brain‐derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS , 2008, The Journal of physiology.

[20]  P. Heuschmann,et al.  Levodopa improves procedural motor learning in chronic stroke patients. , 2008, Archives of physical medicine and rehabilitation.

[21]  J. Rothwell,et al.  Consensus: Motor cortex plasticity protocols , 2008, Brain Stimulation.

[22]  Haruo Kasai,et al.  Protein Synthesis and Neurotrophin-Dependent Structural Plasticity of Single Dendritic Spines , 2008, Science.

[23]  Mauro Maccarrone,et al.  The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. , 2007, Brain : a journal of neurology.

[24]  P. Calabresi,et al.  Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery , 2007, Neurobiology of Disease.

[25]  J. Rothwell,et al.  The after-effect of human theta burst stimulation is NMDA receptor dependent , 2007, Clinical Neurophysiology.

[26]  U. Ziemann,et al.  Modification of practice-dependent plasticity in human motor cortex by neuromodulators. , 2006, Cerebral cortex.

[27]  S. Cramer,et al.  BDNF val66met polymorphism is associated with modified experience-dependent plasticity in human motor cortex , 2006, Nature Neuroscience.

[28]  T. Mima,et al.  Altered plasticity of the human motor cortex in Parkinson's disease , 2006, Annals of neurology.

[29]  B. Pleger,et al.  The NMDA antagonist memantine affects training induced motor cortex plasticity – a study using transcranial magnetic stimulation [ISRCTN65784760] , 2005, BMC Neuroscience.

[30]  D. Ruge,et al.  Learning Modifies Subsequent Induction of Long-Term Potentiation-Like and Long-Term Depression-Like Plasticity in Human Motor Cortex , 2004, The Journal of Neuroscience.

[31]  Karl-Heinz Schulz,et al.  Basal serum levels and reactivity of nerve growth factor and brain-derived neurotrophic factor to standardized acute exercise in multiple sclerosis and controls , 2003, Journal of Neuroimmunology.

[32]  F. Müller,et al.  Effect of levodopa in combination with physiotherapy on functional motor recovery after stroke: a prospective, randomised, double-blind study , 2001, The Lancet.

[33]  Jeff Biernaskie,et al.  Enriched Rehabilitative Training Promotes Improved Forelimb Motor Function and Enhanced Dendritic Growth after Focal Ischemic Injury , 2001, The Journal of Neuroscience.

[34]  P. Tonin,et al.  Effects of fluoxetine and maprotiline on functional recovery in poststroke hemiplegic patients undergoing rehabilitation therapy. , 1996, Stroke.

[35]  E. Kandel,et al.  D1/D5 receptor agonists induce a protein synthesis-dependent late potentiation in the CA1 region of the hippocampus. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[36]  L. Petrucelli,et al.  Further study on the specificity of D-amino acid oxidase and D-aspartate oxidase and time course for complete oxidation of D-amino acids. , 1993, Comparative biochemistry and physiology. B, Comparative biochemistry.

[37]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.

[38]  J. Delgado-García,et al.  Involvement of cannabinoid CB1 receptor in associative learning and in hippocampal CA3-CA1 synaptic plasticity. , 2012, Cerebral Cortex.